Fitness6 months ago
AAV Therapy: A Successful One-Patient SPG50 Gene Therapy Trial
In hereditary spastic paraplegia type 50 (SPG50)—an ultrarare form of neurodevelopmental/neurological disorder described as ideal for gene therapy—Canadian researchers successfully created and completed a phase 1...